Processing

Please wait...

Settings

Settings

Goto Application

1. WO2015125067 - USE OF A CASEIN HYDROLYSATE AS AN ANTIVIRAL AGENT

Publication Number WO/2015/125067
Publication Date 27.08.2015
International Application No. PCT/IB2015/051157
International Filing Date 17.02.2015
IPC
A61K 35/20 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
20Milk; Whey; Colostrum
A61P 31/20 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
20for DNA viruses
CPC
A61K 35/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
20Milk; Whey; Colostrum
A61K 38/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
01Hydrolysed proteins; Derivatives thereof
A61K 38/018
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
01Hydrolysed proteins; Derivatives thereof
012from animals
018from milk
A61K 9/0014
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0014Skin, i.e. galenical aspects of topical compositions
A61K 9/0053
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0053Mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/009
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0087Galenical forms not covered by A61K9/02 - A61K9/7023
009Sachets, pouches characterised by the material or function of the envelope
Applicants
  • NTD LABS, S. L. [ES]/[ES]
Inventors
  • ADELL WINKLER, Pere
  • LOPEZ ZARCO, Guillermo
Agents
  • GALLEGO JIMÉNEZ, José Fernando
Priority Data
20143024824.02.2014ES
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) USE OF A CASEIN HYDROLYSATE AS AN ANTIVIRAL AGENT
(FR) UTILISATION D'UN HYDROLYSAT DE CASÉINE EN TANT QU'AGENT ANTIVIRAL
Abstract
(EN) The present invention relates to the use of a casein hydrolysate as an antiviral agent for the treatment of opportunistic virus infections, especially herpesvirus and human papillomavirus. This casein hydrolysate has an application in both the therapeutic treatment of established symptoms and the prevention of the infection or the reactivation of a latent infection by an opportunistic virus. The casein hydrolysate of the present invention is effective for the prevention of opportunistic virus infections in individuals with weakened immune system.
(FR) La présente invention concerne l'utilisation d'un hydrolysat de caséine en tant qu'agent antiviral pour le traitement d'infections virales opportunistes, en particulier par le virus de l'herpès et le papillomavirus humain. L'hydrolysat de caséine présente une application à la fois pour le traitement thérapeutique de symptômes établis et pour la prévention de l'infection ou de la réactivation d'une infection latente par un virus opportuniste. L'hydrolysat de caséine selon la présente invention est efficace pour la prévention d'infections virales opportunistes chez des individus présentant un système immunitaire affaibli.
Latest bibliographic data on file with the International Bureau